Response of Dairy Cows to High Doses of a Sustained-Release Bovine Somatotropin Administered During Two Lactations. 1. Production Response
- 1 November 1991
- journal article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 74 (11) , 3807-3821
- https://doi.org/10.3168/jds.s0022-0302(91)78573-1
Abstract
This study evaluated the effect of sometribove (zinc methionyl bST) in a sustained-release formulation administered to lactating cows at concentrations up to 3.0 g every 14 d over two lactations. Eighty-two lactating Holstein cows in their first, second, or third lactation were assigned to the study. Cows received .6, 1.8, or 3.0 g of bST in one, three, or five intramuscular injections of a unit dose (.6 g) every 2 wk. Controls received five injections of the vehicle (equivalent volume to the 3.0-g treatment) every 2 wk. Injections were administered from 60 +/- 3 d postpartum until dry-off or necropsy. Thirty-eight animals were continued on treatment for a second consecutive lactation. During the 1st yr of treatment, bST increased mean 3.5% FCM by 7.2, 9.4, and 8.4 kg/d over control production (21.1 kg/d). During the 2nd yr, milk response to .6, 1.8, and 3.0 g of bST averaged 10.6, 3.6, and 4.9 kg/d over controls (24.8 kg/d). The incidence of clinical mastitis increased in the 3.0-g group relative to controls during the 2nd yr. Thus, salable FCM averaged 8.1, 9.1, and 6.2 kg/d above controls (yr 1) and 12.1, 4.7, and -2.8 kg/d (yr 2) for the .6-, 1.8-, and 3.0-g groups. Salable FCM was unaffected by mastitis at a proposed commercial dose (.6 g). Milk fat, protein, lactose, calcium, phosphorus, zinc, magnesium, and ash concentrations were unaffected by bST treatment. Calculated energy, calcium, phosphorus, and protein balances also were unaffected except for early decreases of up to 5 Mcal/d, and 40, 20, and 600 g/d, respectively, until feed intake increased. Milk serum bST concentrations greater than the assay limit of sensitivity (1 ng/ml) were routinely measurable only at doses of 1.8 and 3.0 g. Results confirmed that bST concentrations in milk serum are exceedingly small. Overall, supraphysiological doses of sometribove increased milk production with little effect on composition. No toxic effects of bST were observed.Keywords
This publication has 17 references indexed in Scilit:
- Response of Dairy Cows to High Doses of a Sustained-Release Bovine Somatotropin Administered During Two Lactations. 2. Health and ReproductionJournal of Dairy Science, 1992
- Lactation Response of Dairy Cows Receiving Bovine Somatotropin via Daily Injections or in a Sustained-Release VehicleJournal of Dairy Science, 1990
- Long-Term Evaluation of a Prolonged-Release Formulation of N-Methionyl Bovine Somatotropin in Lactating Dairy CowsJournal of Dairy Science, 1989
- Long-term effects of recombinant bovine somatotropin (rBST) on dairy cow performancesAnimal Research, 1988
- Effect of 188-Day Treatment with Somatotropin on Health and Reproductive Performance of Lactating Dairy Cows,Journal of Dairy Science, 1987
- Responses of High-Producing Dairy Cows to Long-Term Treatment with Pituitary Somatotropin and Recombinant SomatotropinJournal of Dairy Science, 1985
- The effect of injecting or infusing low doses of bovine growth hormone on milk yield, milk composition and the quantity of hormone in the milk serum of cowsAnimal Science, 1985
- Serum Growth Hormone Concentrations after Growth Hormone or Thyrotropin Releasing Hormone in CowsJournal of Dairy Science, 1977
- Growth Hormone-Induced Ketosis in the CowJournal of Dairy Science, 1965
- BIOASSAY OF THE GROWTH HORMONE OF THE ANTERIOR PITUITARY1Endocrinology, 1942